NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC, founded in 1985, is a community nonprofit in the Diseases & Disorders sector that reported $5.8M in total revenue in fiscal year 2024. Revenue fell 39% from the prior year — a significant decline worth monitoring.
TO CREATE, DELIVER, AND PROMOTE COMPREHENSIVE AND COMPASSIONATE CARE AND SUPPORT SERVICES FOR INDIVIDUALS AND FAMILIES AFFECTED BY ALZHEIMER'S DISEASE AND RELATED DEMENTIAS, AND TO ELIMINATE ALZHEIMER'S DISEASE THROUGH THE ADVANCEMENT OF RESEARCH.
FAMILY SUPPORT AND EDUCATION: THE GOAL OF THE FAMILY SUPPORTS & EDUCATION DEPARTMENT IS TO BE A TRUSTED PARTNER READY TO HELP CLIENTS LIVING WITH ALZHEIMER'S OR OTHER COGNITIVE DISORDERS AND FAMILY...
FAMILY SUPPORT AND EDUCATION: THE GOAL OF THE FAMILY SUPPORTS & EDUCATION DEPARTMENT IS TO BE A TRUSTED PARTNER READY TO HELP CLIENTS LIVING WITH ALZHEIMER'S OR OTHER COGNITIVE DISORDERS AND FAMILY CARE PARTNERS AS THEY ARE GOING THROUGH THIS JOURNEY. THE DEPARTMENT IS RESPONSIBLE FOR MULTIPLE SERVICES INCLUDING: HELPLINE, CARE CONSULTATIONS AND COACHING, SUPPORT GROUPS, AND EDUCATION PROGRAMS. OUR AIM IS TO PROVIDE THE SUPPORT, EDUCATION, TOOLS, AND RESOURCES THAT DIAGNOSED INDIVIDUALS AND THEIR CARE PARTNERS NEED TO NAVIGATE THEIR SITUATIONS AND TO EQUIP THEM WITH THE RIGHT QUESTIONS TO ASK.
EARLY-STAGE & ENGAGEMENT SERVICES: FOR INDIVIDUALS IN THE EARLY STAGES OF ALZHEIMER'S AND RELATED DEMENTIAS, CARINGKIND OFFERS PROGRAMS DESIGNED TO ENGAGE AND SUPPORT THEM THROUGH SMALL GROUP...
EARLY-STAGE & ENGAGEMENT SERVICES: FOR INDIVIDUALS IN THE EARLY STAGES OF ALZHEIMER'S AND RELATED DEMENTIAS, CARINGKIND OFFERS PROGRAMS DESIGNED TO ENGAGE AND SUPPORT THEM THROUGH SMALL GROUP PROGRAMS. THESE SERVICES AIM TO HELP INDIVIDUALS MAINTAIN STIMULATION, FOSTER SOCIAL CONNECTIONS, AND ENHANCE OVERALL WELL-BEING.
PUBLIC AWARENESS: VISIBILITY AND AWARENESS OF ALZHEIMER'S AND DEMENTIA CARE ARE ENHANCED THROUGH STRATEGIC MARKETING AND OUTREACH EFFORTS. CAREGIVERS AND FAMILIES ARE INFORMED ABOUT AVAILABLE...
PUBLIC AWARENESS: VISIBILITY AND AWARENESS OF ALZHEIMER'S AND DEMENTIA CARE ARE ENHANCED THROUGH STRATEGIC MARKETING AND OUTREACH EFFORTS. CAREGIVERS AND FAMILIES ARE INFORMED ABOUT AVAILABLE RESOURCES AND SUPPORT TO HELP NAVIGATE THE COMPLEXITIES OF CARE. COMMUNITY ENGAGEMENT IS FOSTERED THROUGH MEDIA CAMPAIGNS, PUBLIC EVENTS LIKE THE ANNUAL WALK AND GALA, AND PARTNERSHIPS, ENSURING THE MESSAGE REACHES THOSE IN NEED. THESE EFFORTS HAVE EXPANDED THE IMPACT, RAISING AWARENESS AND DRIVING PARTICIPATION IN ESSENTIAL SERVICES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $5,802,618 | $9,557,108 | -0.4% |
| Expenses | $6,250,019 | $5,871,032 | +0.1% |
| Net Income | $-447,401 | $3,686,076 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JEFFREY N JONES | CO-CHAIR | 1.50 |
Officer
Director
|
$0 | $0 | $0 |
| LINDA LAGORGA | CO-CHAIR | 0.80 |
Officer
Director
|
$0 | $0 | $0 |
| BETTY J BRENNAN | SECRETARY | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| TODD MATLOVSKY STARTED 1124 | VICE CHAIR & TREASURER | 0.10 |
Officer
Director
|
$0 | $0 | $0 |
| BAL AGRAWAL STARTED 625 | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| BETSY BILLARD ENDED 924 | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| SANDRA S BARON | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| RACHEL BERK | DIRECTOR | 0.20 |
Director
|
$0 | $0 | $0 |
| GAYATRI DEVI MD MS FAAN | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| PATRICK J DOLAN | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| JANE DYSTEL STARTED 1124 | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| MICHAEL FERIK STARTED 625 | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| JOE FISHER | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| MEGHANN GILL | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| ROBERT GLATTER MD | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| JONATHAN S HENES | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| SARAH HOIT | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| ALISA KAUFFMAN DMD PC | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| WAYNE L KAPLAN | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| SHARON K KILMER | DIRECTOR | 0.20 |
Director
|
$0 | $0 | $0 |
| JOHN A MOORE | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| JOANNA PENA-BICKLEY | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| TAMRYN SHAMI | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| ELAINE THOMAS ENDED 625 | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| NIMESH UDESHI | DIRECTOR | 0.20 |
Director
|
$0 | $0 | $0 |
| TIM WALSH | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| THOMAS R WOLZIEN STARTED 125 | DIRECTOR | 0.20 |
Director
|
$0 | $0 | $0 |
| PAULINE YEUNG-HA | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| MARK ZURACK | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| ELEONORA CARMEN TORNATORE | PRESIDENT & CEO | 44.00 |
Officer
|
$287,019 | $14,839 | $301,858 |
| ALEX WONG | CHIEF FINANCIAL OFFICER | 41.00 |
Officer
|
$145,178 | $23,461 | $168,639 |
| ANDREA TALLENT SPIVAK | CHIEF DEVELOPMENT OFFICER | 40.00 |
Highest
|
$142,415 | $10,741 | $153,156 |
| PEGGY CHU | SR. VP, CHIEF OPERATIONS OFFICER | 45.00 |
Highest
|
$135,168 | $23,654 | $158,822 |
| EDWARD CISEK | CHIEF GRANTS & EVALUATION OFFICER | 40.00 |
Highest
|
$134,973 | $20,951 | $155,924 |
| STEPHANI L SHIVERS | CIO & VP PROGRAM DEVELOPMENT | 32.00 |
Highest
|
$157,678 | $8,322 | $166,000 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $5,802,618 | $6,250,019 | $9,462,823 | $-447,401 |
| 2024 | $9,557,108 | $5,871,032 | $10,510,973 | $3,686,076 |
| 2023 | $5,564,426 | $5,197,716 | $7,561,215 | $366,710 |
| 2022 | $6,165,848 | $4,883,031 | $4,860,903 | $1,282,817 |
| 2021 | $4,855,931 | $4,130,176 | $4,187,791 | $725,755 |
| 2020 | $3,485,894 | $4,431,045 | $3,194,996 | $-945,151 |
| 2019 | $6,287,532 | $6,266,256 | $3,692,768 | $21,276 |
| 2018 | $5,789,395 | $7,118,941 | $4,418,558 | $-1,329,546 |
Compare ALZHEIMER'S DISEASE AND RELATED DISORDERS NEW YORK CITY INC with other nonprofits in New York and across the country.